4 views left Get unlimited views with a free account

Explore the latest trends and actionable insights on the Chordoma Pipeline Drugs to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Chordoma by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 34 ongoing clinical trials involving Chordoma
Of the 34 trials,18 trials are in Phase II
Furthermore, 7 trials are in Phase I/II

Number of ongoing Clinical Trials (for drugs) involving Chordoma by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Chordoma, an Oncology indication. The largest number of ongoing clinical trials for Chordoma is conducted in North America. Europe and Asia-Pacific are among some of the other prominent regions involved in Chordoma-related drug trials.

National Cancer Institute US: The leading ongoing Chordoma-related clinical trials sponsor

National Cancer Institute US, the US-based government agency, is the top sponsor for Chordoma-related ongoing clinical trials.

Epizyme Inc, Shanghai Changzheng Hospital, Centre Leon Berard, UNICANCER Group, and John Wayne Cancer Institute are a few other notable sponsors involving Chordoma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.

Explore the latest trends and actionable insights on the Chordoma Pipeline Drugs to inform business strategy and pinpoint opportunities and risks. Explore the latest trends and actionable insights on the Chordoma Pipeline Drugs to inform business strategy and pinpoint opportunities and risks. Visit Report Store